Adagene Enterprise Value over EBITDA from 2010 to 2024
ADAG Stock | USD 2.73 0.09 3.41% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 0.11969785 | Current Value 0.13 | Quarterly Volatility 31.22231529 |
Check Adagene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagene main balance sheet or income statement drivers, such as Tax Provision of 1.8 M, Net Interest Income of 3.3 M or Interest Income of 4.5 M, as well as many exotic indicators such as Price To Sales Ratio of 4.43, Dividend Yield of 0.0109 or PTB Ratio of 1.26. Adagene financial statements analysis is a perfect complement when working with Adagene Valuation or Volatility modules.
Adagene | Enterprise Value over EBITDA |
About Adagene Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Adagene income statement, its balance sheet, and the statement of cash flows. Adagene investors use historical funamental indicators, such as Adagene's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Adagene investors may use each financial statement separately, they are all related. The changes in Adagene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adagene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adagene Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adagene. Please read more on our technical analysis and fundamental analysis pages.
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company was incorporated in 2011 and is headquartered in Suzhou, China. Adagene Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 259 people.
Pair Trading with Adagene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adagene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will appreciate offsetting losses from the drop in the long position's value.Moving against Adagene Stock
0.79 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
0.68 | OPT | Opthea | PairCorr |
0.66 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
0.66 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
0.6 | SUPN | Supernus Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Adagene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adagene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adagene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adagene to buy it.
The correlation of Adagene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adagene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adagene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adagene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Adagene Correlation against competitors. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.Note that the Adagene information on this page should be used as a complementary analysis to other Adagene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Adagene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.414 | Quarterly Revenue Growth (0.85) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.